The Role of Glucocorticoids in the Management of COVID-19

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme
Vasileia Ismini Alexaki, Holger Henneicke

Abstract

Coronavirus disease 2019 (COVID-19), caused by an infection with the novel coronavirus SARS-CoV-2, has resulted in a global pandemic and poses an emergency to public health systems worldwide. COVID-19 is highly infectious and is characterized by an acute respiratory illness that varies from mild flu-like symptoms to the life-threatening acute respiratory distress syndrome (ARDS). As such, there is an urgent need for the development of new therapeutic strategies, which combat the high mortality in severely ill COVID-19 patients. Glucocorticoids are a frontline treatment for a diverse range of inflammatory diseases. Due to their immunosuppressive functions, the use of glucocorticoids in the treatment of COVID-19 patients was initially regarded with caution. However, recent studies concluded that the initiation of systemic glucocorticoids in patients suffering from severe and critical COVID-19 is associated with lower mortality. Herein we review the anti-inflammatory effects of glucocorticoids and discuss emerging issues in their clinical use in the context of COVID-19.

References

Feb 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·F S Dhabhar, B S McEwen
May 4, 2000·The New England Journal of Medicine·UNKNOWN Acute Respiratory Distress Syndrome NetworkArthur Wheeler
Jun 17, 2000·Journal of Leukocyte Biology·A van der GoesC D Dijkstra
Jan 5, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jerome GalonStefan R Bornstein
Apr 4, 2003·The Biochemical Journal·Christina WidénAnn-Charlotte Wikström
Mar 10, 2004·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·L MozoC Gutiérrez
Nov 17, 2004·Annals of Internal Medicine·Li WeiBrian R Walker
Mar 5, 2005·Ophthalmology·Sylvie Feldman-BillardEmmanuel Héron
Jan 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Dapeng WangHolger M Reichardt
Jun 2, 2006·Arthritis and Rheumatism·Jeffrey R CurtisKenneth G Saag
Jun 9, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·J K YangJ C N Chan
Feb 13, 2007·Trends in Molecular Medicine·Mark LöwenbergDaniel W Hommes
May 16, 2007·The British Journal of Dermatology·L FardetJ Cabane
Jun 26, 2007·Respirology : Official Journal of the Asian Pacific Society of Respirology·Ritesh AgarwalDheeraj Gupta
Nov 15, 2007·Intensive Care Medicine·G Umberto MeduriDjillali Annane
Aug 8, 2008·Annals of the Rheumatic Diseases·D HuscherF Buttgereit
Mar 4, 2011·The New England Journal of Medicine·Sreenivasa Rao Kondapally SeshasaiUNKNOWN Emerging Risk Factors Collaboration
Mar 13, 2012·European Journal of Endocrinology·Rebecca M ReynoldsUNKNOWN Edinburgh Type 2 Diabetes study investigators
Dec 12, 2012·Nature Structural & Molecular Biology·William H HudsonEric A Ortlund
Jan 15, 2013·Trends in Endocrinology and Metabolism : TEM·John M Busillo, John A Cidlowski
May 22, 2013·The New England Journal of Medicine·Claude GuérinUNKNOWN PROSEVA Study Group
Aug 21, 2013·Proceedings of the National Academy of Sciences of the United States of America·Waldemar KanczkowskiStefan R Bornstein
Oct 10, 2013·Frontiers in Neuroendocrinology·Chun-Lei JiangJeffrey G Tasker
Dec 3, 2014·Pharmacology & Therapeutics·Ioannis MitroulisTriantafyllos Chavakis
Jan 15, 2015·Nature Communications·Masanori MiyataJian-Dong Li
Feb 24, 2016·JAMA : the Journal of the American Medical Association·Giacomo BellaniUNKNOWN ESICM Trials Group
May 25, 2016·PLoS Medicine·Lionel Rostaing, Paolo Malvezzi
Dec 27, 2016·Frontiers in Immunology·Karolina A ZielińskaPhilippe E Van den Steen
Feb 14, 2017·Nature Reviews. Immunology·Derek W Cain, John A Cidlowski
Aug 31, 2017·Journal of Translational Medicine·Guo-Wei TuZhe Luo
Nov 22, 2017·American Journal of Respiratory and Critical Care Medicine·Yaseen M ArabiUNKNOWN Saudi Critical Care Trial Group
Dec 1, 2018·Trends in Pharmacological Sciences·Reynold A PanettieriOmar Tliba
Jul 25, 2019·Frontiers in Immunology·Steven TimmermansClaude Libert

❮ Previous
Next ❯

Methods Mentioned

BETA
sumoylation

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.